placebo injection: Clinical Trials

45 trials of placebo injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 5 recruiting, 5 terminated, 5 unknown. 45 Phase 2, 7 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 245Completed 25, Recruiting 5, Terminated 5, Unknown 5, Not yet recruiting 3, Active not recruiting 1, Suspended 1
Phase 37Completed 5, Not yet recruiting 1, Recruiting 1
Phase 13Completed 2, Terminated 1

Follow placebo injection: new trials by email Literature Review of placebo injection trials Research Report on placebo injection

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients
LP-003 Injection, Placebo Injection - Peanut Allergies
Phase 2Not yet recruitingLongbio Pharma (Suzhou) Co., Ltd.802026-12-012026-11-12
Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department
Ketamine Injectable Solution, Placebo Injection, Crisis Response Plan - Suicidal Ideation
Phase 2RecruitingThe University of Texas Health Science Center at San Antonio2002026-09-302026-10-15
Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection
Platelet-Rich Plasma (PRP) Injections, Saline (0.9% NaCl) - Thumb Osteoarthritis
Phase 2RecruitingGoed Medisch Centrum882026-05-202026-10-05
Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis
LP-005 Injection, Placebo Injection - Periodontitis
Phase 2Not yet recruitingLongbio Pharma (Suzhou) Co., Ltd.1002026-05-012026-05-22
Modulation of Cerebral Ischemia by Albumin
Albumin infusion, Placebo Injection - Ischemic Stroke
Phase 2RecruitingUniversity Hospital Hradec Kralove1002026-02-032026-05-06
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Umbilical Cord-Derived Mesenchymal Stem Cells, Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes, Placebo Intracavernosal Injection - Erectile Dysfunction With Diabetes Mellitus
Phase 2 / Phase 3RecruitingAnkara City Hospital Bilkent902025-12-292026-03-18
Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment
Supplemental Postoperative Bupivacaine, Placebo Injection - Pain Assessment, Quality of Life (QOL)
Phase 2RecruitingNew York University1502024-11-012026-11-10
A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea
HRS9531 Injection, Placebo Injection - Weight Management
Phase 2UnknownFujian Shengdi Pharmaceutical Co., Ltd.1082024-08-012024-08-22
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
CM313 Injection, Placebo Injection - Immune Thrombocytopenia, Treatment
Phase 2Active not recruitingInstitute of Hematology & Blood Diseases Hospital, China452024-01-162024-12-30
A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
HS-20094, Placebo - Overweight and Obesity
Phase 2CompletedJiangsu Hansoh Pharmaceutical Co., Ltd.2002023-10-162026-06-04
NVG-291 in Spinal Cord Injury Subjects
NVG-291, Placebo Injection - Spinal Cord Injuries, Chronic Spinal Cord Injury
Phase 1 / Phase 2CompletedNervGen Pharma242023-08-082026-11-20
Monthly Injectable BUP for MA Use Disorder (MURB) Trial
Buprenorphine injection (BUP-Inj), Placebo injection - Methamphetamine-dependence
Phase 2TerminatedMadhukar H. Trivedi, MD182023-03-242025-03-21
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
Dengzhanxixin Injection, Placebo injection - Acute Ischemic Stroke
Phase 2UnknownBeijing Tiantan Hospital2402022-09-302023-01-26
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
Compound Edaravone Injection-Low dose, Compound Edaravone Injection-High dose, Edaravone Injection - Acute Ischemic Stroke
Phase 2SuspendedNanjing Yoko Biomedical Co., Ltd.2402021-11-152024-02-20
Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19)
Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or high dose BCD-250 injection - Coronavirus Infection, COVID-19
Phase 1 / Phase 2TerminatedBiocad502021-08-102023-01-30
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)
Supaglutide injection, placebo injection - Type2 Diabetes
Phase 2 / Phase 3CompletedShanghai Yinnuo Pharmaceutical Technology Co., Ltd.5472021-08-032024-08-07
A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
Sepranolone injection low dose, Sepranolone injection high dose, Placebo injection - Menstrual Migraine
Phase 2CompletedAsarina Pharma862019-08-272021-07-26
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Semaglutide Injectable Product, Placebo - HIV/AIDS, Lipohypertrophy
Phase 2CompletedCase Western Reserve University1082019-05-162026-10-27
Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease
Lixisenatide, placebo - Parkinson Disease
Phase 2CompletedUniversity Hospital, Toulouse1562018-06-132025-11-28

Showing 20 of 45. Sign in to see all of them.

Conditions studied

Ischemic Stroke (3)  ·  Sciatica (3)  ·  Spinal Cord Injuries (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Bone Resorption (2)  ·  Brain Injuries, Traumatic (2)  ·  Central Nervous System Diseases (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Endocrine System Diseases (2)  ·  Genital Diseases, Male (2)  ·  Gonadal Disorders (2)  ·  Hypogonadism (2)  ·  Motor Activity (2)  ·  Myocardial Ischemia (2)  ·  Nervous System Diseases (2)

Sponsors

Longbio Pharma (Suzhou) Co., Ltd. (2)  ·  PhaseBio Pharmaceuticals Inc. (2)  ·  VA Office of Research and Development (2)  ·  Adynxx, Inc. (1)  ·  Ankara City Hospital Bilkent (1)  ·  Asarina Pharma (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Beijing Tiantan Hospital (1)  ·  Biocad (1)  ·  Bonti, Inc. (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Case Western Reserve University (1)  ·  Christine M. Kleinert Institute for Hand and Microsurgery (1)  ·  Eli Lilly and Company (1)

Countries

United States (26)  ·  China (7)  ·  France (3)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  Finland (1)  ·  Iran (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Joshua F Yarrow, PhD MS BS (2)  ·  Allison R Eckard, MD (1)  ·  Anne R. Cappola, MD, ScM (1)  ·  Colleen Fitzgerald, MD (1)  ·  Dalong Zhu, M.D,Ph.D (1)  ·  Dana M Otzel, PhD (1)  ·  Dennis M. Black, PhD (1)  ·  Donald C Manning, MD, PhD (1)  ·  Earvin Liang (1)  ·  Erkan Olcucuoglu, MD, Associate Professor (1)

Results publications

PMID 19805702, PMID 20506391, PMID 21737787, PMID 22773240, PMID 22791766, PMID 23137499, PMID 23589163, PMID 24793366, PMID 25387217, PMID 26166166, PMID 27151378, PMID 27518486, PMID 28546090, PMID 30224390, PMID 30445896, PMID 30489516, PMID 34438333, PMID 37184744, PMID 38319239, PMID 38598572, PMID 38964353, PMID 39356039, PMID 39722695, PMID 39961992, PMID 40160348, PMID 40744729, PMID 41098140, PMID 41107649, PMID 41120215, PMID 41272211, PMID 42752515, PMID 42921178

NIH funding

2023 (1), I01RX001449 (1), K23AG019161 (1), P30DK019525 (1), R01DA025223 (1), R01DK121619 (1), UL1RR024150 (1)